A historical cycle of scarcity and survival presents an opportunity for outsized returns in the often misunderstood medical technology investment market.
OTIF is pleased to have led a £1m investment in Panda Surgical, a next-generation neurosurgical robotics company emerging from University College London. This investment underscores our commitment to backing advanced life-science ventures with strong intellectual property and high-impact potential.
Launch of Quantum-AI Data Centre is a flagship initiative of the UK–US Tech Trade Partnership announced by President Trump and Prime Minister Starmer
The acquisition will see Brill Power technology incorporated into PETL BESS systems immediately to provide world leading BESS solutions.
OTIF participated in a £5m investment supporting the combined venture, alongside FirstGroup plc, Barclays Climate Ventures and Oxford University.
We are delighted that OTIF Ventures portfolio company OrganOx has accepted an acquisition offer by Terumo Medical Corporation, a leading global medical technology company headquartered in Japan, in a transaction valued at $1.5 billion USD.
This reflects a 12x multiple from the first OTIF investment in 2016.